Overview

Neoadjuvant Radiotherapy Combined With Toripalimab for Locally Advanced Head and Neck Squamous Cell Carcinoma

Status:
Not yet recruiting

Trial end date:
2025-05-20

Target enrollment:

Participant gender:

Summary

This is a phase II study. Twenty-three patients with locally advanced head and neck squamous cell carcinoma were planned to be enrolled to assess the efficacy and safety of neoadjuvant immunotherapy combined with radiotherapy.

Phase:

Phase 2

Details

Lead Sponsor:

Tianjin Medical University General Hospital

Collaborator:

Tianjin Medical University Cancer Institute and Hospital